메뉴 건너뛰기




Volumn 77, Issue 1, 2011, Pages 3-8

Desensitization: Achieving immune detente

Author keywords

Desensitization; Human leukocyte antigen antibodies; Incompatible transplantation; Positive crossmatch

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; BORTEZOMIB; CALCINEURIN INHIBITOR; CD20 ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; DEOXYSPURGUALIN; ECULIZUMAB; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

EID: 78650032792     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01596.x     Document Type: Review
Times cited : (13)

References (56)
  • 1
    • 38449089313 scopus 로고    scopus 로고
    • The problem of transplanting the sensitized patient whose problem is it?
    • Jackson AM, Zachary AA. The problem of transplanting the sensitized patient whose problem is it? Front Biosci 2008: 13: 1396-412.
    • (2008) Front Biosci , vol.13 , pp. 1396-1412
    • Jackson, A.M.1    Zachary, A.A.2
  • 2
    • 0023083856 scopus 로고
    • Public epitopes and the antigenic structure of the HLA molecules.
    • Rodey GE, Fuller TC. Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol 1987: 7: 229-67.
    • (1987) Crit Rev Immunol , vol.7 , pp. 229-267
    • Rodey, G.E.1    Fuller, T.C.2
  • 3
    • 33750365602 scopus 로고    scopus 로고
    • Immunoregulation by targeting T cells in the treatment of allergy and asthma.
    • Larché M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006: 18: 745-50.
    • (2006) Curr Opin Immunol , vol.18 , pp. 745-750
    • Larché, M.1
  • 4
    • 70449901330 scopus 로고    scopus 로고
    • An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes.
    • Ozdemir C. An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes. Ther Adv Respir Dis 2009: 3: 253-63.
    • (2009) Ther Adv Respir Dis , vol.3 , pp. 253-263
    • Ozdemir, C.1
  • 5
    • 0142103746 scopus 로고    scopus 로고
    • Intravenous immune globulins: an update for clinicians.
    • Knezevic-Maramic I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003: 43: 1460-80.
    • (2003) Transfusion , vol.43 , pp. 1460-1480
    • Knezevic-Maramic, I.1    Kruskall, M.S.2
  • 6
    • 0025102027 scopus 로고
    • Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
    • Sullivan KM, Kopecky KJ, Jocom J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990: 323: 705-12.
    • (1990) N Engl J Med , vol.323 , pp. 705-712
    • Sullivan, K.M.1    Kopecky, K.J.2    Jocom, J.3
  • 7
    • 0027228037 scopus 로고
    • Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg).
    • Glotz D, Haymann J-P, Sansonetti N et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). Transplantation 1993: 56: 335-7.
    • (1993) Transplantation , vol.56 , pp. 335-337
    • Glotz, D.1    Haymann, J.2    Sansonetti, N.3
  • 8
    • 0042838104 scopus 로고    scopus 로고
    • Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    • Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003: 76: 631-6.
    • (2003) Transplantation , vol.76 , pp. 631-636
    • Jordan, S.C.1    Vo, A.2    Bunnapradist, S.3
  • 9
    • 9644262465 scopus 로고    scopus 로고
    • Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    • Jordan SC, Tyan D, Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004: 15: 3256-62.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 3256-3262
    • Jordan, S.C.1    Tyan, D.2    Stablein, D.3
  • 10
    • 77951823581 scopus 로고    scopus 로고
    • Use of intravenous immune globulin and Rituximab for desensitization of highly HLA-Sensitized patients awaiting kidney transplantation.
    • Vo AA, Peng A, Toyoda M et al. Use of intravenous immune globulin and Rituximab for desensitization of highly HLA-Sensitized patients awaiting kidney transplantation. Transplantation 2010: 89: 1095-102.
    • (2010) Transplantation , vol.89 , pp. 1095-1102
    • Vo, A.A.1    Peng, A.2    Toyoda, M.3
  • 11
    • 67651027514 scopus 로고    scopus 로고
    • Intravenous immunoglobulin a natural regulator of immunity and inflammation.
    • Jordan SC, Toyoda M, Vo AA. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation 2009: 88: 1-6.
    • (2009) Transplantation , vol.88 , pp. 1-6
    • Jordan, S.C.1    Toyoda, M.2    Vo, A.A.3
  • 12
    • 0345237270 scopus 로고    scopus 로고
    • Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.
    • John R, Lietz K, Burke E et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999: 100 II: 229-35.
    • (1999) Circulation , vol.100 , Issue.2 , pp. 229-235
    • John, R.1    Lietz, K.2    Burke, E.3
  • 13
    • 18144386902 scopus 로고    scopus 로고
    • Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
    • Appel JZ, Hartwig MG, Davis RD, Reinsmoen NL. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum Immunol 2005: 66: 378-86.
    • (2005) Hum Immunol , vol.66 , pp. 378-386
    • Appel, J.Z.1    Hartwig, M.G.2    Davis, R.D.3    Reinsmoen, N.L.4
  • 14
    • 0032572976 scopus 로고    scopus 로고
    • Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.
    • Jordan SC, Quartel AW, Czer LS et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998: 66: 800-5.
    • (1998) Transplantation , vol.66 , pp. 800-805
    • Jordan, S.C.1    Quartel, A.W.2    Czer, L.S.3
  • 15
    • 0035863090 scopus 로고    scopus 로고
    • A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.
    • Casadei DH, Del C rial M, Opelz G et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001: 71: 53-8.
    • (2001) Transplantation , vol.71 , pp. 53-58
    • Casadei, D.H.1    Del C rial, M.2    Opelz, G.3
  • 16
    • 2442677763 scopus 로고    scopus 로고
    • Intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.
    • Moger V, RaviShankar MS, Sakjuja V et al. Intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2004: 77: 1455-6.
    • (2004) Transplantation , vol.77 , pp. 1455-1456
    • Moger, V.1    RaviShankar, M.S.2    Sakjuja, V.3
  • 17
    • 33645002093 scopus 로고    scopus 로고
    • Clearance studies during subsequent sessions of double filtration plasmapheresis.
    • Yeh JH, Chen WH, Chiu HC, Bai CH. Clearance studies during subsequent sessions of double filtration plasmapheresis. Artif Organs 2006: 30: 111-4.
    • (2006) Artif Organs , vol.30 , pp. 111-114
    • Yeh, J.H.1    Chen, W.H.2    Chiu, H.C.3    Bai, C.H.4
  • 19
    • 37549049397 scopus 로고    scopus 로고
    • Double-filtration plasmapheresis.
    • Tanabe K. Double-filtration plasmapheresis. Transplantation 2007: 84: S30-2.
    • (2007) Transplantation , vol.84
    • Tanabe, K.1
  • 20
    • 0031881657 scopus 로고    scopus 로고
    • Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose.
    • Braun N, Gutenberger S, Erley CM, Risler T. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose. Transfus Sci 1998: 19 (Suppl): 25-31.
    • (1998) Transfus Sci , vol.19 , Issue.SUPPL , pp. 25-31
    • Braun, N.1    Gutenberger, S.2    Erley, C.M.3    Risler, T.4
  • 21
    • 32544450007 scopus 로고    scopus 로고
    • Desensitization protocols improving access and outcome in transplantation.
    • Zachary AA, Montgomery RA, Leffell MS. Desensitization protocols improving access and outcome in transplantation. Clin Appl Immunol Rev 2005: 5: 373-95.
    • (2005) Clin Appl Immunol Rev , vol.5 , pp. 373-395
    • Zachary, A.A.1    Montgomery, R.A.2    Leffell, M.S.3
  • 22
    • 11144232667 scopus 로고    scopus 로고
    • Transplanting patients with a positive donor-specific crossmatch: a single center's perspective.
    • Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplantation 2004: 8: 535-42.
    • (2004) Pediatr Transplantation , vol.8 , pp. 535-542
    • Montgomery, R.A.1    Zachary, A.A.2
  • 23
    • 0035993661 scopus 로고    scopus 로고
    • Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.
    • Sonnenday CJ, Ratner LE, Zachary AA et al. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc 2002: 34: 1614-6.
    • (2002) Transplant Proc , vol.34 , pp. 1614-1616
    • Sonnenday, C.J.1    Ratner, L.E.2    Zachary, A.A.3
  • 24
    • 0344152841 scopus 로고    scopus 로고
    • Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
    • Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003: 76: 1519-25.
    • (2003) Transplantation , vol.76 , pp. 1519-1525
    • Zachary, A.A.1    Montgomery, R.A.2    Ratner, L.E.3
  • 25
    • 0034721477 scopus 로고    scopus 로고
    • Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidney to be successfully transplanted into cross-match positive recipients.
    • Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidney to be successfully transplanted into cross-match positive recipients. Transplantation 2000: 70: 887-95.
    • (2000) Transplantation , vol.70 , pp. 887-895
    • Montgomery, R.A.1    Zachary, A.A.2    Racusen, L.C.3
  • 26
    • 77953958281 scopus 로고    scopus 로고
    • Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.
    • Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res 2010: 47: 257-64.
    • (2010) Immunol Res , vol.47 , pp. 257-264
    • Warren, D.S.1    Montgomery, R.A.2
  • 27
    • 0034722728 scopus 로고    scopus 로고
    • A high panel-reactive antibody rescue protocol for cross-match positive live donor kidney transplant.
    • Schweitzer EJ, Wilson JS, Fernandez-Vina M. A high panel-reactive antibody rescue protocol for cross-match positive live donor kidney transplant. Transplantation 2000: 70: 1531-36.
    • (2000) Transplantation , vol.70 , pp. 1531-1536
    • Schweitzer, E.J.1    Wilson, J.S.2    Fernandez-Vina, M.3
  • 28
    • 10744232533 scopus 로고    scopus 로고
    • Overcoming a positive crossmatch in living-donor kidney transplantation.
    • Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003: 34: 1017-23.
    • (2003) Am J Transplant , vol.34 , pp. 1017-1023
    • Gloor, J.M.1    DeGoey, S.R.2    Pineda, A.A.3
  • 29
    • 59649116354 scopus 로고    scopus 로고
    • Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    • Thielke JJ, West-Thielke PM, Herren HL et al. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Transplantation 2009: 87: 268-73.
    • (2009) Transplantation , vol.87 , pp. 268-273
    • Thielke, J.J.1    West-Thielke, P.M.2    Herren, H.L.3
  • 30
    • 76649096333 scopus 로고    scopus 로고
    • Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunologic risk.
    • Flores-Gama F, Mondragón-Ramirez GA, Bochicchio- Riccardelli T. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunologic risk. Cir Cir 2009: 77: 369-74.
    • (2009) Cir Cir , vol.77 , pp. 369-374
    • Flores-Gama, F.1    Mondragón-Ramirez, G.A.2    Bochicchio- Riccardelli, T.3
  • 31
    • 0033038283 scopus 로고    scopus 로고
    • Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report.
    • Furth S, Neu AM, Hart J, Zachary A, Colomban P, Fivush BA. Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report. Pediatr Transplant 1999: 3: 149-49.
    • (1999) Pediatr Transplant , vol.3 , pp. 149-249
    • Furth, S.1    Neu, A.M.2    Hart, J.3    Zachary, A.4    Colomban, P.5    Fivush, B.A.6
  • 32
    • 10744228964 scopus 로고    scopus 로고
    • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.
    • Rocha PN, Butterly DW, Greenberg A et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003: 75: 1490-5.
    • (2003) Transplantation , vol.75 , pp. 1490-1495
    • Rocha, P.N.1    Butterly, D.W.2    Greenberg, A.3
  • 33
    • 4544296842 scopus 로고    scopus 로고
    • Successful rescue therapy with plasmapoheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
    • White NB, Greenstein SM, Cantafio AW et al. Successful rescue therapy with plasmapoheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004: 78: 772-74.
    • (2004) Transplantation , vol.78 , pp. 772-774
    • White, N.B.1    Greenstein, S.M.2    Cantafio, A.W.3
  • 34
    • 18144382600 scopus 로고    scopus 로고
    • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
    • Lehrich RW, Rocha PN, Reinsmoen N et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 2005: 66: 350-58.
    • (2005) Hum Immunol , vol.66 , pp. 350-358
    • Lehrich, R.W.1    Rocha, P.N.2    Reinsmoen, N.3
  • 35
    • 29544447059 scopus 로고    scopus 로고
    • Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    • Ibernon M, Gil-Vernet S, Carrera M et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 2005: 37: 3743-5.
    • (2005) Transplant Proc , vol.37 , pp. 3743-3745
    • Ibernon, M.1    Gil-Vernet, S.2    Carrera, M.3
  • 36
    • 0032775558 scopus 로고    scopus 로고
    • Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.
    • Pisani BA, Mullen Gm, Malinowska K et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1999: 18: 701-6.
    • (1999) J Heart Lung Transplant , vol.18 , pp. 701-706
    • Pisani, B.A.1    Mullen, G.2    Malinowska, K.3
  • 37
    • 33745629586 scopus 로고    scopus 로고
    • Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin.
    • Leech SH, Lopez-Cepero M, LeFor WM et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 2006: 20: 476-84.
    • (2006) Clin Transplant , vol.20 , pp. 476-484
    • Leech, S.H.1    Lopez-Cepero, M.2    LeFor, W.M.3
  • 38
    • 34748914694 scopus 로고    scopus 로고
    • Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
    • Pollock-BarZiv SM, Den Hollander N, Ngan BY et al. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 2007: 116 (Suppl 1): 172-8.
    • (2007) Circulation , vol.116 , Issue.SUPPL 1 , pp. 172-178
    • Pollock-BarZiv, S.M.1    Den Hollander, N.2    Ngan, B.Y.3
  • 39
    • 0023576832 scopus 로고
    • Present experiences in a series of 26 ABO-incompatible living donor renal allografts.
    • Alexandre GP, Squifflet JP, DeBruyere M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987: 19: 4538-48.
    • (1987) Transplant Proc , vol.19 , pp. 4538-4548
    • Alexandre, G.P.1    Squifflet, J.P.2    DeBruyere, M.3
  • 40
    • 33947580557 scopus 로고    scopus 로고
    • Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation - single center analysis.
    • Ishida H, Mayamoto N, Shirakawa H et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation - single center analysis. Am J Transplant 2007: 7: 825-31.
    • (2007) Am J Transplant , vol.7 , pp. 825-831
    • Ishida, H.1    Mayamoto, N.2    Shirakawa, H.3
  • 41
    • 59849096365 scopus 로고    scopus 로고
    • Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    • Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Contrib Nephrol 2009: 162: 61-74.
    • (2009) Contrib Nephrol , vol.162 , pp. 61-74
    • Tanabe, K.1    Ishida, H.2    Shimizu, T.3    Omoto, K.4    Shirakawa, H.5    Tokumoto, T.6
  • 43
    • 3042746307 scopus 로고    scopus 로고
    • Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.
    • Sonnenday CJ, Warren DS, Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004: 4: 1315-22.
    • (2004) Am J Transplant , vol.4 , pp. 1315-1322
    • Sonnenday, C.J.1    Warren, D.S.2    Cooper, M.3
  • 44
    • 32544442087 scopus 로고    scopus 로고
    • ABO incompatible high titer renal transplantation without splenectomy or anti-CD20 treatment.
    • Segev DL, Simpkins CE, Warren DS et al. ABO incompatible high titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005: 5: 2570-5.
    • (2005) Am J Transplant , vol.5 , pp. 2570-2575
    • Segev, D.L.1    Simpkins, C.E.2    Warren, D.S.3
  • 45
    • 65549126350 scopus 로고    scopus 로고
    • ABO incompatible renal transplantation: a paradigm ready for broad implementation.
    • Montgomery RA, Locke JE, King KE et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009: 87: 1246-55.
    • (2009) Transplantation , vol.87 , pp. 1246-1255
    • Montgomery, R.A.1    Locke, J.E.2    King, K.E.3
  • 46
    • 77951210109 scopus 로고    scopus 로고
    • ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation.
    • Tobian AAR, Shirey RS, Montgomery RA et al. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant 2010: 10: 1247-53.
    • (2010) Am J Transplant , vol.10 , pp. 1247-1253
    • Tobian, A.A.R.1    Shirey, R.S.2    Montgomery, R.A.3
  • 47
    • 3943110993 scopus 로고    scopus 로고
    • Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    • Gloor MM, DeGoey S, Ploeger N et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004: 78: 221-7.
    • (2004) Transplantation , vol.78 , pp. 221-227
    • Gloor, M.M.1    DeGoey, S.2    Ploeger, N.3
  • 48
    • 34247241237 scopus 로고    scopus 로고
    • 14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation.
    • Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FJH, Reed EF. 14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation. Tissue Antigens 2007: 69 (Suppl 1): 160-73.
    • (2007) Tissue Antigens , vol.69 , Issue.SUPPL 1 , pp. 160-173
    • Zachary, A.A.1    Montgomery, R.A.2    Jordan, S.C.3    Reinsmoen, N.L.4    Claas, F.J.H.5    Reed, E.F.6
  • 49
    • 77952041825 scopus 로고    scopus 로고
    • Barriers to successful transplantation of the sensitized patient.
    • Zachary AA, Leffell MS. Barriers to successful transplantation of the sensitized patient. Expert Rev Clinc Immunol 2010: 6: 449-60.
    • (2010) Expert Rev Clinc Immunol , vol.6 , pp. 449-460
    • Zachary, A.A.1    Leffell, M.S.2
  • 50
    • 33745865957 scopus 로고    scopus 로고
    • Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration.
    • Jindra PR, Zhang X, Mulder A et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006: 82: S33-5.
    • (2006) Transplantation , vol.82
    • Jindra, P.R.1    Zhang, X.2    Mulder, A.3
  • 51
    • 4444319472 scopus 로고    scopus 로고
    • Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway.
    • Narayanan K, Jaramillo A, Phelan DL, Mohanakumar T. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 2004: 34: 2303-12.
    • (2004) Eur J Immunol , vol.34 , pp. 2303-2312
    • Narayanan, K.1    Jaramillo, A.2    Phelan, D.L.3    Mohanakumar, T.4
  • 52
    • 70350132232 scopus 로고    scopus 로고
    • Effect of antibodies on endothelium.
    • Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009: 9: 2459-65.
    • (2009) Am J Transplant , vol.9 , pp. 2459-2465
    • Zhang, X.1    Reed, E.F.2
  • 53
    • 68049147592 scopus 로고    scopus 로고
    • Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.
    • Locke JE, Zachary AA, Warren DS. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant 2009: 9: 2136-9.
    • (2009) Am J Transplant , vol.9 , pp. 2136-2139
    • Locke, J.E.1    Zachary, A.A.2    Warren, D.S.3
  • 54
    • 67649619522 scopus 로고    scopus 로고
    • Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients.
    • Kopchaliiska D, Zachary AA, Montgomery RA, Leffell MS. Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients. Transplantation 2009: 87: 1394-401.
    • (2009) Transplantation , vol.87 , pp. 1394-1401
    • Kopchaliiska, D.1    Zachary, A.A.2    Montgomery, R.A.3    Leffell, M.S.4
  • 55
    • 18144419717 scopus 로고    scopus 로고
    • Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.
    • Zachary AA, Montgomery RA, Leffell MS. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 2005: 66: 364-70.
    • (2005) Hum Immunol , vol.66 , pp. 364-370
    • Zachary, A.A.1    Montgomery, R.A.2    Leffell, M.S.3
  • 56
    • 76949097232 scopus 로고    scopus 로고
    • Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols.
    • Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010: 10: 449-57.
    • (2010) Am J Transplant , vol.10 , pp. 449-457
    • Montgomery, R.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.